Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Acumen

    Client Virtual Booth

    ACUMEN

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Acumen Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    427 Park St. Charlottesville, VA 22902
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://acumenpharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acumen-pharm/
    Twitter
    Twitter
    https://twitter.com/acumenpharm

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Acumen Presents Sabirnetug (ACU193) Data at American Academy of Neurology 2024
    Acumen Presents Sabirnetug (ACU193) Data at American Academy of Neurology 2024

    https://www.globenewswire.com/news-release/2024/04/16/2863530/0/en/Acumen-Pharmaceuticals-Presents-First-Comprehensive-Clinical-and-Biomarker-Data-for-Sabirnetug-ACU193-at-American-Academy-of-Neurology-2024-Annual-Meeting.html

    GLOBENEWSWIRE
    16 Apr 2024
    Share Share
    Lonza, Acumen Pharmaceuticals Ink Alzheimer’s Alliance
    Lonza, Acumen Pharmaceuticals Ink Alzheimer’s Alliance

    https://www.contractpharma.com/contents/view_breaking-news/2024-04-04/lonza-acumen-pharmaceuticals-ink-alzheimers-alliance/

    CONTRACT PHARMA
    04 Apr 2024
    Share Share
    Acumen Collab with Lonza to Advance Sabirnetug for the Treatment of AD
    Acumen Collab with Lonza to Advance Sabirnetug for the Treatment of AD

    https://www.globenewswire.com/news-release/2024/04/04/2857726/0/en/Acumen-Pharmaceuticals-Collaborates-with-Lonza-to-Advance-Sabirnetug-for-the-Treatment-of-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    04 Apr 2024
    Share Share
    Acumen Reports Financial Results for the Year Ended December 31, 23
    Acumen Reports Financial Results for the Year Ended December 31, 23

    https://www.globenewswire.com/news-release/2024/03/26/2852230/0/en/Acumen-Pharmaceuticals-Reports-Financial-Results-for-the-Year-Ended-December-31-2023-and-Business-Highlights.html

    GLOBENEWSWIRE
    26 Mar 2024
    Share Share
    Acumen to Present Sabirnetug (ACU193), During Session at the AAN Meeting
    Acumen to Present Sabirnetug (ACU193), During Session at the AAN Meeting

    https://www.globenewswire.com/news-release/2024/03/21/2850184/0/en/Acumen-Pharmaceuticals-to-Present-Deeper-Insights-Including-Fluid-Biomarker-Data-for-Sabirnetug-ACU193-During-Emerging-Science-Session-at-the-American-Academy-of-Neurology-Annual-M.html

    GLOBENEWSWIRE
    21 Mar 2024
    Share Share
    Acumen to Report Fourth Quarter & Year-End 2023 Financial Results
    Acumen to Report Fourth Quarter & Year-End 2023 Financial Results

    https://www.globenewswire.com/news-release/2024/03/19/2848953/0/en/Acumen-Pharmaceuticals-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-on-March-26-2024.html

    GLOBENEWSWIRE
    19 Mar 2024
    Share Share
    Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
    Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

    https://www.globenewswire.com//news-release/2024/03/12/2844985/0/en/Acumen-Pharmaceuticals-to-Participate-in-the-Stifel-2024-CNS-Days.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker
    Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker

    https://www.globenewswire.com/news-release/2024/03/08/2843122/0/en/Acumen-Pharmaceuticals-Presents-Sabirnetug-ACU193-Fluid-Biomarker-and-Target-Engagement-Analyses-from-Phase-1-INTERCEPT-AD-Study-in-Early-Alzheimer-s-at-the-AD-PD-2024-Annual-Meeti.html

    GLOBENEWSWIRE
    08 Mar 2024
    Share Share
    Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker
    Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker

    https://www.globenewswire.com//news-release/2024/02/21/2832702/0/en/Acumen-Pharmaceuticals-to-Present-Sabirnetug-ACU193-Fluid-Biomarker-and-Target-Engagement-Analyses-from-Phase-1-INTERCEPT-AD-Study-in-Early-Alzheimer-s-at-the-AD-PD-2024-Annual-Mee.html

    GLOBENEWSWIRE
    21 Feb 2024
    Share Share
    Acumen Appoints Dr. James Doherty as President and Chief Development Officer
    Acumen Appoints Dr. James Doherty as President and Chief Development Officer

    https://www.globenewswire.com//news-release/2024/02/01/2821827/0/en/Acumen-Pharmaceuticals-Appoints-Dr-James-Doherty-as-President-and-Chief-Development-Officer.html

    GLOBENEWSWIRE
    01 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search